ISLAND PHARMACEUTICALS LIMITED

0.00%

18.5¢

Market Cap $43.67M

Healthcare Biotechnology

Island Pharmaceuticals Ltd is an Australia-based drug repurposing company. The Company is... Island Pharmaceuticals Ltd is an Australia-based drug repurposing company. The Company is focused on areas of unmet need for antiviral therapeutics to address infectious diseases. Its lead asset is ISLA-101, a drug with a safety profile being repurposed for the prevention and treatment of dengue2 fever and other mosquito (or vector) borne diseases. ISLA-101 has been shown to have activity against all four strains of dengue virus as well as other flaviviruses such as Zika virus, West Nile virus, and Yellow Fever virus, as well as Chikungunya virus. While ISLA-101 is an oral formulation, the Company is also considering alternative formulations, including a long-acting oral formulation and intravenous formulations for severe dengue infections. The Company operates a single segment, being research and development activities principally in the geographic regions of Australia and the United States. Its subsidiary is Isla Pharmaceuticals Inc.More

ASX:AFP

Could this ASX stock become the next Pfizer? A look at AFT Pharmaceuticals (ASX:AFP). With biotech stocks broadly having a strong run in 2025, and with more of the year ahead, investors are still looking for stocks in the sector with room to run.

Latest Threads

Tag

Subject

ILA

Ann: Successful Phase 2 clinical trial of ISLA-101

18:58

16K

18:58

Last post TenthMan

16K

ILA

Chart

12/06/25

28K

12/06/25

Last post italabria

28K

ILA

ILA - Media coverage

12/06/25

27K

12/06/25

Last post Teeth

27K

ILA

ILA chart

12/06/25

5.2K

12/06/25

Last post bushmaster

5.2K

ILA

Ann: Trading Halt

12/06/25

7.7K

12/06/25

Last post italabria

7.7K

ILA

Ann: Phase 2a/b clinical trial update

10/06/25

21K

10/06/25

Last post thechino

21K

ILA

ILA Industry news

04/06/25

10K

04/06/25

Last post Brucekoala

10K

ILA

Ann: Cleansing Notice

04/06/25

742

04/06/25

Last post thechino

742

See All Discussions

Timeline

Successful Phase 2 clinical trial of ISLA-101
12 Jun 09:53	Share

Trading Halt
10 Jun 09:13	Share

Cleansing Notice
04 Jun 08:30	Share

Application for quotation of securities - ILA
04 Jun 08:27	Share

Change in substantial holding
03 Jun 13:06	Share

Change in substantial holding
02 Jun 07:31	Share

Change in substantial holding
29 May 14:10	Share

Cleansing Notice
29 May 08:52	Share

Application for quotation of securities - ILA
29 May 08:48	Share

Proposed issue of securities - ILA
21 May 09:09	Share

Proposed issue of securities - ILA
21 May 09:09	Share

Proposed issue of securities - ILA
21 May 09:08	Share

Island completes $3.6 million placement
21 May 09:08	Share

Trading Halt
19 May 09:41	Share

Investor Presentation
08 May 08:49	Share

Quarterly Activities & Cashflow Report
30 Apr 08:31	Share

Phase 2a/b clinical trial update
23 Apr 09:12	Share

Notification of cessation of securities - ILA
14 Apr 09:35	Share

Change in substantial holding
26 Mar 16:21	Share

Ceasing to be a substantial holder
25 Mar 16:35	Share

Change in substantial holding
25 Mar 16:31	Share

Change in substantial holding
24 Mar 16:14	Share

Spark Plus Healthcare Conference Investor Presentation
24 Mar 09:35	Share

Change in substantial holding
21 Mar 09:35	Share

Total of $2.72m raised from ILAO options
19 Mar 09:51	Share

Notification of cessation of securities - ILA
19 Mar 09:29	Share

Change of Director's Interest Notice - PL
19 Mar 09:13	Share

Application for quotation of securities - ILA
19 Mar 09:09	Share

Application for quotation of securities - ILA
12 Mar 09:13	Share

Change of Director's Interest Notice - DF
05 Mar 08:37	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 18.5¢		Change 0.000(0.00%)		Mkt cap ! $43.67M

Open	High	Low	Value	Volume
18.5¢	19.0¢	17.0¢	$107.4K	601.9K

Buyers (Bids)

No.	Vol.	Price($)
1	5000	17.5¢

Sellers (Offers)

Price($)	Vol.	No.
18.0¢	58773	1

View Market Depth

No.	Vol.	Price($)
1	5000	0.175
4	34393	0.170
3	80472	0.165
4	201032	0.160
5	140383	0.155

Price($)	Vol.	No.
0.190	130093	2
0.195	120000	2
0.200	60303	2
0.205	25000	1
0.220	69077	3

Last trade - 15.55pm 13/06/2025 (20 minute delay)


Last 18.0¢		Change 0.000 ( 0.22 %)
Open	High	Low	Volume
18.0¢	18.0¢	17.0¢	260459
Last updated 15.59pm 13/06/2025 ?

ILA (ASX) Chart

ISLAND PHARMACEUTICALS LIMITED

Latest Threads

Gold, Brent Crude spike as Israel strikes Iran in worst-case scenario

Timeline

Featured News

Latest Videos

Island Pharmaceuticals (ASX:ILA) receives FDA feedback on clinical trial application

01 Feb 2023 15:53 (AEDT)

Latest Articles

Island enrols first subjects for Phase 2b clinical trial for dengue fever drug

Island Pharmaceuticals has enrolled its first four participants in a Phase 2b clinical trial to test ISLA-101 as progress rolls on.

Island Pharma's anti-dengue drug trial set to hit Phase 2b in Jan 2025 with FDA happy

Island Pharma has reported witnessing anti-dengue 'activity' in Phase 2a readout results of its ISLA-101 drug.

Island Pharmaceuticals (ASX:ILA) receives $1.96m grant to support ISLA-101 clinical development

Island Pharmaceuticals (ASX:ILA) has received a $1.96 million grant to support phase 2a human clinical trials of its ISLA-101 dengue fever treatment.

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News